Page results
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
UCLH works in partnership with GPs in Barnet and Enfield to provide a community based ear, nose and throat (ENT) service. The Community ENT service provides specialist advice and treatment for a range of minor ENT conditions.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the abdomen.
-
This page is to help prepare you and the family for your child’s radiotherapy treatment under a general anaesthetic.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
File results
-
FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment
-
FOI/2023/0809 - Equality, Diversity and Inclusion staff spend/ improved patient outcomes
-
FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy
-
FOI/2023/0811 - HIFU partial ablation/ prostate cancer detection
-
FOI/2023/0813 - Ulcerative colitis/ crohn's disease
-
FOI/2023/0815 - Birth data; live births/ stillbirths/ neonatal deaths
-
FOI/2023/0817 - Bed sores, pressure sores and pressure ulcers statistics
-
FOI/2023/0822 - Bank staff pay rates
-
FOI/2023/0827 - Consultation on future of EDS services
-
FOI/2023/0829 - Immunoglobulin treatments